The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Links

 

Gene Review

CEBPB  -  CCAAT/enhancer binding protein (C/EBP), beta

Homo sapiens

Synonyms: C/EBP beta, C/EBP-beta, CCAAT/enhancer-binding protein beta, CRP2, IL6DBP, ...
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of CEBPB

 

High impact information on CEBPB

  • Functional NF-IL6/CCAAT enhancer-binding protein is required for tumor necrosis factor alpha-inducible expression of the granulocyte colony-stimulating factor (CSF), but not the granulocyte/macrophage CSF or interleukin 6 gene in human fibroblasts [6].
  • In addition, NF-IL6 is known to form heterodimeric complexes with the NF-kappa B transcription factor, which is also engaged in the transcriptional regulation of these genes [7].
  • Functional NF-IL6/CCAAT enhancer-binding protein is required for tumor necrosis factor alpha-inducible expression of the granulocyte colony-stimulating factor (CSF), but not the granulocyte/macrophage CSF or interleukin 6 gene in human fibroblasts [7].
  • The indispensable importance of NF-IL6 for regulating gene expression of proinflammatory cytokine genes in response to inflammatory stimuli in vivo remains, however, unclear [7].
  • LAP (NF-IL6) transactivates the collagen alpha 1(I) gene from a 5' regulatory region [8].
  • CEBPB expression in humans (peripheral blood leukocytes) is found to correlate with muscle strength [9]. Higher expression of CEBPB is hypothesized to reflect a greater proportion of alternatively differentiated macrophages that perform the repair of muscle after injury, based on the cited study in humans and the following evidence from mice [10].
 

Chemical compound and disease context of CEBPB

 

Biological context of CEBPB

  • Within this DNA fragment, there were two novel 9-bp motifs (-90/-82 and -40/-32) with high homology to the nuclear factor-IL6 (NF-IL6) binding site [13].
  • These data demonstrate that RelA and members of the C/EBP/NF-IL-6 family can functionally cooperate in transcriptional activation of the IL-8 gene and suggest a common mechanism for inducible regulation of cytokine gene expression [14].
  • Mutational analyses of RelA demonstrate that the C-terminal transactivation domain and the DNA binding domain are required for synergistic activation with NF-IL-6 [14].
  • Our studies show that HSF1 represses the lipopolyliposaccharide-induced transcription of the IL-1beta promoter through direct interaction with the nuclear factor of interleukin 6 (NF-IL6, also known as CCAAT enhancer binding protein (C/EBPbeta), an essential regulator in IL-1beta transcription [15].
  • Exploring transcription factor binding properties of several non-coding DNA sequence elements in the human NF-IL6 gene [16].
 

Anatomical context of CEBPB

 

Associations of CEBPB with chemical compounds

  • We have previously reported in human normal TEC that clustering of the laminin receptor alpha6beta4 integrin induced by thymocyte contact or monoclonal antibody-mediated cross-linking regulates IL-6 gene expression via activation of NF-kappaB and NF-IL6 transactivators [20].
  • The anti-inflammatory glucocorticoid dexamethasone inhibited NF-kappaB translocation and the promoter binding of NF-kappaB, AP-1, and NF-IL-6 [21].
  • Furthermore, exogenous prostaglandin E2 stimulated AP-1 and NF-IL-6 binding to the IL-8 promoter [21].
  • Cockroach extract-induced regulation of NF-IL6 was due to active serine proteases in the extract as well as activation of protease activated receptor (PAR)-2, but not PAR-1 [22].
  • Taken together, the results suggest that asbestos-induced redox changes and phosphorylation events, mediated by staurosporine-sensitive and tyrosine kinase(s), activate nuclear proteins which recognize the NF-kappaB/NF-IL-6 binding sites of the IL-8 promoter and contribute to the regulation of IL-8 gene expression [23].
 

Physical interactions of CEBPB

  • We show for the first time that HSF1 binds directly to NF-IL6 in vivo and antagonizes its activity [15].
  • In this regard, it is noteworthy that both an NF-IL6 binding site and an NFkB binding site are present in the inducible genes such as IL-6, IL-8, and several acute-phase genes [4].
  • Mutation of either the AP-1 or NF-IL6 binding site did not abolish IL-8 gene repression by dexamethasone, suggesting that these sites were not targets for dexamethasone [24].
  • In addition, HSF2 is not capable of binding to NF-IL6 [25].
  • Based on the results obtained from the present study, we conclude that the IL1B promoter is a Tax-responsive sequence as a result of ability of Tax to induce binding of NF-IL6 and Spi-1 to the IL1B promoter sequence through protein-protein interaction [26].
 

Regulatory relationships of CEBPB

 

Other interactions of CEBPB

 

Analytical, diagnostic and therapeutic context of CEBPB

  • Furthermore, CEBPB has been mapped to 20q13.1 by fluorescence in situ hybridization [32].
  • Southern blot analysis demonstrated the high-degree conservation of the NF-IL6 gene through evolution and the existence of several other related genes sharing the DNA-binding domain [27].
  • NF-IL6 protein, however, was detected in nuclear extracts of these cells by Western blotting [33].
  • The nuclear factor interleukin-6 (NF-IL6) and signal transducer and activator of transcription-3 (STAT-3) signalling pathways co-operate to mediate the activation of the hsp90beta gene by interleukin-6 but have opposite effects on its inducibility by heat shock [34].
  • A high-resolution radiation hybrid map encompassing 9.5 Mb between the PLC and the CEBPB genes was constructed using 68 markers: 25 polymorphic markers, 15 known genes, 21 ESTs, and 7 random genomic sequences [35].

 

References

  1. Activation of transcription factors NF-kappaB and NF-IL-6 by human immunodeficiency virus type 1 protein R (Vpr) induces interleukin-8 expression. Roux, P., Alfieri, C., Hrimech, M., Cohen, E.A., Tanner, J.E. J. Virol. (2000) [Pubmed]
  2. Protein kinase R, IkappaB kinase-beta and NF-kappaB are required for human rhinovirus induced pro-inflammatory cytokine production in bronchial epithelial cells. Edwards, M.R., Hewson, C.A., Laza-Stanca, V., Lau, H.T., Mukaida, N., Hershenson, M.B., Johnston, S.L. Mol. Immunol. (2007) [Pubmed]
  3. Activation of the interleukin 6 gene by Mycobacterium tuberculosis or lipopolysaccharide is mediated by nuclear factors NF-IL6 and NF-kappa B. Zhang, Y., Broser, M., Rom, W.N. Proc. Natl. Acad. Sci. U.S.A. (1994) [Pubmed]
  4. IL-6 and NF-IL6 in acute-phase response and viral infection. Akira, S., Kishimoto, T. Immunol. Rev. (1992) [Pubmed]
  5. Induction of interleukin 6 (IL-6) by hypoxia in vascular cells. Central role of the binding site for nuclear factor-IL-6. Yan, S.F., Tritto, I., Pinsky, D., Liao, H., Huang, J., Fuller, G., Brett, J., May, L., Stern, D. J. Biol. Chem. (1995) [Pubmed]
  6. Functional NF-IL6/CCAAT enhancer-binding protein is required for tumor necrosis factor alpha-inducible expression of the granulocyte colony-stimulating factor (CSF), but not the granulocyte/macrophage CSF or interleukin 6 gene in human fibroblasts. Adler, G. J. Exp. Med. (1997) [Pubmed]
  7. Functional NF-IL6/CCAAT enhancer-binding protein is required for tumor necrosis factor alpha-inducible expression of the granulocyte colony-stimulating factor (CSF), but not the granulocyte/macrophage CSF or interleukin 6 gene in human fibroblasts. Kiehntopf, M., Herrmann, F., Brach, M.A. J. Exp. Med. (1995) [Pubmed]
  8. LAP (NF-IL6) transactivates the collagen alpha 1(I) gene from a 5' regulatory region. Houglum, K., Buck, M., Adir, V., Chojkier, M. J. Clin. Invest. (1994) [Pubmed]
  9. CCAAT-enhancer-binding protein-beta expression in vivo is associated with muscle strength. Harries, L.W., Pilling, L.C., Hernandez, L.D., Bradley-Smith, R., Henley, W., Singleton, A.B., Guralnik, J.M., Bandinelli, S., Ferrucci, L., Melzer, D. Aging. Cell. (2012) [Pubmed]
  10. A CREB-C/EBPbeta cascade induces M2 macrophage-specific gene expression and promotes muscle injury repair. Ruffell, D., Mourkioti, F., Gambardella, A., Kirstetter, P., Lopez, R.G., Rosenthal, N., Nerlov, C. Proc. Natl. Acad. Sci. U. S. A. (2009) [Pubmed]
  11. Retinoid antagonism of NF-IL6: insight into the mechanism of antiproliferative effects of retinoids in Kaposi's sarcoma. Nagpal, S., Cai, J., Zheng, T., Patel, S., Masood, R., Lin, G.Y., Friant, S., Johnson, A., Smith, D.L., Chandraratna, R.A., Gill, P.S. Mol. Cell. Biol. (1997) [Pubmed]
  12. Convergent regulation of NF-IL6 and Oct-1 synthesis by interleukin-6 and retinoic acid signaling in embryonal carcinoma cells. Hsu, W., Chen-Kiang, S. Mol. Cell. Biol. (1993) [Pubmed]
  13. Regulation of the interleukin-1 beta (IL-1 beta) gene by mycobacterial components and lipopolysaccharide is mediated by two nuclear factor-IL6 motifs. Zhang, Y., Rom, W.N. Mol. Cell. Biol. (1993) [Pubmed]
  14. Synergistic transcriptional activation of the IL-8 gene by NF-kappa B p65 (RelA) and NF-IL-6. Kunsch, C., Lang, R.K., Rosen, C.A., Shannon, M.F. J. Immunol. (1994) [Pubmed]
  15. Heat shock factor 1 represses transcription of the IL-1beta gene through physical interaction with the nuclear factor of interleukin 6. Xie, Y., Chen, C., Stevenson, M.A., Auron, P.E., Calderwood, S.K. J. Biol. Chem. (2002) [Pubmed]
  16. Exploring transcription factor binding properties of several non-coding DNA sequence elements in the human NF-IL6 gene. Pares-Matos, E.I., Milligan, J.S., Bina, M. J. Mol. Biol. (2006) [Pubmed]
  17. Activation of transcription factor IL-6 (NF-IL-6) and nuclear factor-kappaB (NF-kappaB) by lipid ozonation products is crucial to interleukin-8 gene expression in human airway epithelial cells. Kafoury, R.M., Hernandez, J.M., Lasky, J.A., Toscano, W.A., Friedman, M. Environ. Toxicol. (2007) [Pubmed]
  18. Transcriptional regulation of cyclooxygenase-2 in the human microvascular endothelial cell line, HMEC-1: control by the combinatorial actions of AP2, NF-IL-6 and CRE elements. Kirtikara, K., Raghow, R., Laulederkind, S.J., Goorha, S., Kanekura, T., Ballou, L.R. Mol. Cell. Biochem. (2000) [Pubmed]
  19. Transcription of a minimal promoter from the NF-IL6 gene is regulated by CREB/ATF and SP1 proteins in U937 promonocytic cells. Berrier, A., Siu, G., Calame, K. J. Immunol. (1998) [Pubmed]
  20. p38 MAPK is a critical regulator of the constitutive and the beta4 integrin-regulated expression of IL-6 in human normal thymic epithelial cells. Mainiero, F., Colombara, M., Antonini, V., Strippoli, R., Merola, M., Poffe, O., Tridente, G., Ramarli, D. Eur. J. Immunol. (2003) [Pubmed]
  21. Transcriptional regulation of interleukin (IL)-8 by bradykinin in human airway smooth muscle cells involves prostanoid-dependent activation of AP-1 and nuclear factor (NF)-IL-6 and prostanoid-independent activation of NF-kappaB. Zhu, Y.M., Bradbury, D.A., Pang, L., Knox, A.J. J. Biol. Chem. (2003) [Pubmed]
  22. German cockroach proteases regulate interleukin-8 expression via nuclear factor for interleukin-6 in human bronchial epithelial cells. Page, K., Hughes, V.S., Odoms, K.K., Dunsmore, K.E., Hershenson, M.B. Am. J. Respir. Cell Mol. Biol. (2005) [Pubmed]
  23. Asbestos induction of nuclear transcription factors and interleukin 8 gene regulation. Simeonova, P.P., Luster, M.I. Am. J. Respir. Cell Mol. Biol. (1996) [Pubmed]
  24. Novel mechanism of glucocorticoid-mediated gene repression. Nuclear factor-kappa B is target for glucocorticoid-mediated interleukin 8 gene repression. Mukaida, N., Morita, M., Ishikawa, Y., Rice, N., Okamoto, S., Kasahara, T., Matsushima, K. J. Biol. Chem. (1994) [Pubmed]
  25. Heat shock factor 1 contains two functional domains that mediate transcriptional repression of the c-fos and c-fms genes. Xie, Y., Zhong, R., Chen, C., Calderwood, S.K. J. Biol. Chem. (2003) [Pubmed]
  26. Human T-cell leukemia virus type I Tax transactivates the promoter of human prointerleukin-1beta gene through association with two transcription factors, nuclear factor-interleukin-6 and Spi-1. Tsukada, J., Misago, M., Serino, Y., Ogawa, R., Murakami, S., Nakanishi, M., Tonai, S., Kominato, Y., Morimoto, I., Auron, P.E., Eto, S. Blood (1997) [Pubmed]
  27. A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family. Akira, S., Isshiki, H., Sugita, T., Tanabe, O., Kinoshita, S., Nishio, Y., Nakajima, T., Hirano, T., Kishimoto, T. EMBO J. (1990) [Pubmed]
  28. Interleukin (IL)-1 and IL-4 synergistically stimulate NF-IL6 activity and IL-6 production in human mesangial cells. Nakazato, Y., Hayashida, T., Kanno, Y., Sasamura, H., Okada, H., Suzuki, H., Saruta, T. Kidney Int. (1998) [Pubmed]
  29. The role of NF-kappa B and NF-IL6 transactivating factors in the synergistic activation of human serum amyloid A gene expression by interleukin-1 and interleukin-6. Betts, J.C., Cheshire, J.K., Akira, S., Kishimoto, T., Woo, P. J. Biol. Chem. (1993) [Pubmed]
  30. Tissue-specific regulation of IL-6 production by IL-4. Differential effects of IL-4 on nuclear factor-kappa B activity in monocytes and fibroblasts. Donnelly, R.P., Crofford, L.J., Freeman, S.L., Buras, J., Remmers, E., Wilder, R.L., Fenton, M.J. J. Immunol. (1993) [Pubmed]
  31. Transcriptional induction of cyclooxygenase-2 gene by okadaic acid inhibition of phosphatase activity in human chondrocytes: co-stimulation of AP-1 and CRE nuclear binding proteins. Miller, C., Zhang, M., He, Y., Zhao, J., Pelletier, J.P., Martel-Pelletier, J., Di Battista, J.A. J. Cell. Biochem. (1998) [Pubmed]
  32. The CCAAT/enhancer binding protein (C/EBP alpha) gene (CEBPA) maps to human chromosome 19q13.1 and the related nuclear factor NF-IL6 (C/EBP beta) gene (CEBPB) maps to human chromosome 20q13.1. Hendricks-Taylor, L.R., Bachinski, L.L., Siciliano, M.J., Fertitta, A., Trask, B., de Jong, P.J., Ledbetter, D.H., Darlington, G.J. Genomics (1992) [Pubmed]
  33. Regulation of spontaneous and TNF/IFN-induced IL-6 expression in two human ovarian-carcinoma cell lines. Asschert, J.G., Vellenga, E., Ruiters, M.H., de Vries, E.G. Int. J. Cancer (1999) [Pubmed]
  34. The nuclear factor interleukin-6 (NF-IL6) and signal transducer and activator of transcription-3 (STAT-3) signalling pathways co-operate to mediate the activation of the hsp90beta gene by interleukin-6 but have opposite effects on its inducibility by heat shock. Stephanou, A., Isenberg, D.A., Akira, S., Kishimoto, T., Latchman, D.S. Biochem. J. (1998) [Pubmed]
  35. A physical map of the 20q12-q13.1 region associated with type 2 diabetes. Price, J.A., Brewer, C.S., Howard, T.D., Fossey, S.C., Sale, M.M., Ji, L., Krolewski, A.S., Bowden, D.W. Genomics (1999) [Pubmed]
 
WikiGenes - Universities